A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
Titel:
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
Auteur:
Jansen, Yanina Kruse, Vibeke Corthals, Jurgen Schats, Kelly van Dam, Pieter-Jan Seremet, Teofila Heirman, Carlo Brochez, Lieve Kockx, Mark Thielemans, Kris Neyns, Bart